Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy

Helen H W Chen, Wen Chung Chen, Zhang Dong Liang, Wen Bin Tsai, Yan Long, Isamu Aiba, Siqing Fu, Russell Broaddus, Jinsong Liu, Lynn G Feun, Niramol Savaraj, Macus Tien Kuo

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Introduction: Platinum (Pt)-based antitumor agents remain important chemotherapeutic agents for treating many human malignancies. Elevated expression of the human high-affinity copper transporter 1 (hCtr1), resulting in enhanced Pt drug transport into cells, has been shown to be associated with improved treatment efficacy. Thus, targeting hCtr1 upregulation is an attractive strategy for improving the treatment efficacy of Pt-based cancer chemotherapy.Area covered: Regulation of hCtr1 expression by cellular copper homeostasis is discussed. Association of elevated hCtr1 expression with intrinsic sensitivity of ovarian cancer to Pt drugs is presented. Mechanism of copper-lowering agents in enhancing hCtr1-mediated cis-diamminedichloroplatinum (II) (cisplatin, cDDP) transport is reviewed. Applications of copper chelation strategy in overcoming cDDP resistance through enhanced hCtr1 expression are evaluated.Expert opinion: While both transcriptional and post-translational mechanisms of hCtr1 regulation by cellular copper bioavailability have been proposed, detailed molecular insights into hCtr1 regulation by copper homeostasis remain needed. Recent clinical study using a copper-lowering agent in enhancing hCtr1-mediated drug transport has achieved incremental improvement in overcoming Pt drug resistance. Further improvements in identifying predictive measures in the subpopulation of patients that can benefit from the treatment are needed.

Original languageEnglish (US)
Pages (from-to)1307-1317
Number of pages11
JournalExpert Opinion on Therapeutic Targets
Volume19
Issue number10
DOIs
StatePublished - Oct 3 2015

Keywords

  • Cisplatin
  • copper chelators
  • copper homeostasis
  • hCtr1
  • high-affinity copper transporter 1
  • platinum drug cancer chemotherapy
  • Sp1

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Fingerprint Dive into the research topics of 'Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy'. Together they form a unique fingerprint.

  • Cite this

    Chen, H. H. W., Chen, W. C., Liang, Z. D., Tsai, W. B., Long, Y., Aiba, I., Fu, S., Broaddus, R., Liu, J., Feun, L. G., Savaraj, N., & Kuo, M. T. (2015). Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy. Expert Opinion on Therapeutic Targets, 19(10), 1307-1317. https://doi.org/10.1517/14728222.2015.1043269